authors
- Crump, M
- Leber, Brian
- Buckstein, R
- Kassis, J
- Matthews, JH
- Robinson, S
- Turner, R
- Hedley, D
- Petrenciuc, O
- McIntosh, L
- Seymour, L
A randomized phase I clinical and biologic study of two schedules of the raf-kinase inhibitor BAY 43-9006 in patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML): A NCI Canada clinical trials group study
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- November 16, 2002
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- 1114 Paediatrics and Reproductive Medicine (FoR)
- Immunology (Science Metrix)
published in
- Blood Journal